Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Turin, Italy
University of Arkansas
University of Arkansas
University of Arkansas
City of Hope Medical Center
Weill Medical College of Cornell University
Roswell Park Cancer Institute
University of Leeds
St. Petersburg State Pavlov Medical University